Search Results - "Samko, A.N."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
  2. 2

    Pharmacological preconditioning by Nicorandil in prevention of ischaemic myocardial injury during an elective percutaneous coronary intervention by Soboleva, G, Gostishev, R.V, Rogoza, A.N, Kotkina, T.I, Samko, A.N, Soboleva, T.V, Karpov, Y.A

    Published in European heart journal (01-11-2020)
    “…Abstract Introduction Elective percutaneous coronary intervention (PCI) is accompanied by intraoperative ischemic myocardial injury (IIMI) up to 30% of the…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Pathological Remodeling of the Myocardium in Chronic Heart Failure: Role of PGC-1[alpha] by Kulikova, T.G, Stepanova, O.V, Voronova, A.D, Valikhov, M.P, Sirotkin, V.N, Zhirov, I.V, Tereshchenko, S.N, Masenko, V.P, Samko, A.N, Sukhikh, G.T

    “…Pathological remodeling of the myocardium in chronic heart failure includes the development of pathological cardiac hypertrophy, reactivation of the fetal…”
    Get full text
    Journal Article
  7. 7

    Safety, inhibition of platelet aggregation and pharmacokinetics of F(ab′) 2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty by Mazurov, A.V., Pevzner, D.V., Antonova, O.A., Byzova, T.V., Khaspekova, S.G., Semenov, A.V., Vlasik, T.N., Samko, A.N., Staroverov, I.I., Ruda, M.Ya

    Published in Platelets (Edinburgh) (01-01-2002)
    “…The purpose of the study was to evaluate safety, effects on platelet aggregation and pharmacokinetics of F(ab') 2 fragments of anti-glycoprotein (GP) IIb-IIIa…”
    Get full text
    Journal Article
  8. 8
  9. 9